Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly

Neurodegeneration

Volumn 4, Issue 3, 1995, Pages 291-297

  Zhan, Shan Shan ^a   Veerhuis, Robert ^a   Kamphorst, Wouter ^a   Eikelenboom, Piet ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Alzheimer's disease; A associated proteins

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B; CORE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROTEOHEPARAN SULFATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CEREBELLUM CORTEX; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CASE-CONTROL STUDIES; CEREBELLAR CORTEX; CEREBRAL CORTEX; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGE; NERVE TISSUE PROTEINS; REFERENCE VALUES;

EID: 0028787769     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1016/1055-8330(95)90018-7     Document Type: Article

References (38)

1. Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques
3. Interleukin-6 and a-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
4. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein
5. Subtypes and differential laminar distributions of β/A4 deposits in Alzheimer's disease: relationship with intellectual status of 26 cases
6. Immunoglobulins and complement factors in senile plaques
7. Complement activation in amyloid plaques in Alzheimer's dementia
8. Neuroimmunological mechanisms in cerebral amyloid deposition in Alzheimer's disease
9. Structure of pentameric human serum amyloid P component
10. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
11. Secretion-Capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans
12. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain
13. Diffuse plaques occur commonly in the cerebellum in Alzheimer's disease
14. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease
15. Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease
16. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain
17. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
18. Distribution of clusterin in Alzheimer brain tissue
19. Differential distribution of lactoferrin and Alz-50 immunoreactivities in neuritic plaques and neurofibrillary tangles in Alzheimer's disease
20. Complement activation by β-amyloid in Alzheimer's disease
21. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition
22. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family
23. Distribution pattern and functional state of α1 antichymotrypsin in plaques and vascular amyloid
24. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer disease senile plaque neurites and neuropil threads
25. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
26. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain
27. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar β-Amylod in rat brain
28. Detection of interleukin-6 and α2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients
29. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues
30. Role of inflammation and complement activation in Alzheimer's disease
31. Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease
32. 1q
33. Apolipoprotein E: a Pathological chaperone protein in patients with cerebral and systemic amyloid
34. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein
35. Two types of dystrophic neurites in senile plaques of Alzheimer disease and elderly non-demented cases
36. Immunohistochemical distribution of the inhibitors of the terminal complement complex in Alzheimer's disease
37. Distribution of neuronal growth promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly